中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Volume 36 Issue 9
Sep.  2020
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2020  >  36(9): 1970-1974

Effect of intraoperative Viatorr stent implantation for shunting of blood flow in the left or right branch of the portal vein and its effect on clinical outcome in patients with cirrhotic portal hypertension undergoing transjugular intrahepatic portosystemic shunt

DOI: 10.3969/j.issn.1001-5256.2020.09.012

  • Department of Gastroenterology, The General Hospital of Western Theater Command

Research funding:

 

  • Published Date: 2020-09-20
    Abstract

  • Objective To investigate the effect of intraoperative Viatorr stent implantation for shunting of blood flow in the left or right branch of the portal vein on the clinical outcome of patients with cirrhotic portal hypertension undergoing transjugular intrahepatic portosystemic shunt( TIPS). Methods A retrospective analysis was performed for the clinical data of 120 patients with cirrhotic portal hypertension who underwent TIPS in The General Hospital of Western Theater Command from March 2016 to December 2019,and according to the target position of portal vein puncture determined by intraoperative angiography,the patients were divided into left branch group and right branch group.The two groups were compared in terms of the incidence rates of postoperative recurrence and bleeding,stent dysfunction,and hepatic encephalopathy( HE) and survival. The t-test was used for comparison of continuous data between two groups,and the chi-square test was used for comparison of categorical data between two groups. The Kaplan-Meier curve was used to calculate rebleeding rate,stent patency rate,incidence rate of HE,and survival rate. Results The surgical success rate was 100% for all 120 patients,with a short-term hemostasis rate of100%. Among the 120 patients,52 underwent shunting of the left branch of the portal vein and 68 underwent shunting of the right branch.There was a significant reduction in portal venous pressure after surgery( 9. 98 ± 2. 84 mm Hg vs 24. 72 ± 5. 11 mm Hg,t = 37. 76,P < 0. 01).The cumulative rebleeding rates at 12 and 24 months after surgery were 3. 2% and 11. 0%,respectively,and the cumulative incidence rates of HE at 3,6,12,and 24 months after surgery were 10. 8%,13. 6%,21. 2%,and 24. 5%,respectively. Among the 29 patients who experienced HE,23 had gradeⅠ-ⅡHE and 6 had grade Ⅲ HE. The cumulative incidence rates of stent dysfunction at 12 and 24 months after surgery were 7. 1% and 21. 4%,respectively. The cumulative survival rates at 12 and 24 months after surgery were 92. 0% and 86. 5%,respectively.As for comparison of the left branch group and the right branch group,there were no significant differences in postoperative stent patency rate,rebleeding rate,incidence rate of HE,and survival rate( all P < 0. 05). Conclusion TIPS is a safe and effective method for the treatment of cirrhotic portal hypertension,and intraoperative Viatorr stent implantation,no matter for establishing the shunt of the left or right branch of the portal vein,will not affect the clinical outcome of patients.

     

    • FullText(HTML)
    • References(22)
  • [1] MALK J,HOLAJ R,KRUPICˇKOVZ,et al. Arteriovenous fistula after femoral artery puncture leading to pulmonary edema:The role of ultrasonography[J]. Prague Med Rep,2012,113(1):49-52.
    [2] CASTILLO-SANG M,TSANG AW,ALMAROOF B,et al. Femoral artery complications after cardiac catheterization:A study of patient profile[J]. Ann Vasc Surg,2010,24(3):328-335.
    [3] QIN JP,TANG W,TANG SH,et al. Modifiedtransjugular intrahepatic portosystemic shunt in the treatment of portal hypertemion of liver cirrhosis[J]. Chin J Dig,2014,34(1):33-36.(in Chinese)秦建平，唐文，汤善宏，等．改良经颈静脉肝内门体静脉分流术治疗肝硬化门静脉高压症[J]．中华消化学杂志，2014,34(1):33-36.
    [4] YAO X,ZHOU H,TANG SH,et al. Stent dysfunction after transjugular intrahepatic portosystemic stent:Causes and countermeasures[J]. J Clin Hepatol,2019,35(5):1052-1056.(in Chinese)姚欣，周昊，汤善宏，等．经颈静脉肝内门体分流术后支架功能障碍的原因分析及处理策略[J]．临床肝胆病杂志，2019,35(5):1052-1056.
    [5] Interventional Group,Chinese Society of Radiology,Chinese Medical Association. Expert consensus on transjugular intrahepatic portosystemic shunt[J]. J Clin Hepatol,2017,33(7):1218-1228.(in Chinese)中华医学会放射学分会介入学组．经颈静脉肝内门体分流术专家共识[J]．临床肝胆病杂志，2017,33(7):1218-1228.
    [6] The Chinese College of Interventionalists. CCI clinical practice guidelines:Management of TIPS for portal hypertension(2019edition)[J]. J Clin Hepatol,2019,35(12):2694-2699.(in Chinese)中国医师协会介入医师分会．中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019年版)[J]．临床肝胆病杂志，2019,35(12):2694-2699.
    [7] Group of Gastrointestinal Intervention,Chinese Society of Gastroenterology, Chinese Medical Association. Consensus on transjugular intrahepatic portosystemic shunt for treatment of cirrhotic portal hypertension[J]. J Clin Hepatol,2014,30(3):210-213.(in Chinese)中华医学会消化病学分会消化介入学组．经颈静脉肝内门体静脉分流术治疗肝硬化门静脉高压共识意见[J]．临床肝胆病杂志，2014,30(3):210-213.
    [8] THOMAS DB,HASKAL ZJ. The role of transjugular intrahepatic portosystemic shunt(TIPS)in the management of portal hypertension:Update 2009[J]. Hepatology,2010,51(1):386-400.
    [9] QIN JP,TANG SH,JIANG MD,et al. Contrast enhanced computed tomography and reconstruction of hepatic vascular system for transjugular intrahepatic portal systemic shunt puncture path planning[J]. World J Gastroenterol,2015,21(32):9623-9629.
    [10] TANG SH,QIN JP,JIANG MD,et al. The agreement and clinical value of hepatic vein pressure gradient and portal vein pressure in patients with portal hypertension[J]. Chin J Hepatol,2015,23(5):354-357.(in Chinese)汤善宏，秦建平，蒋明德，等．门静脉高压患者肝静脉压力梯度与门静脉压相关性及其临床价值[J]．中华肝脏病杂志，2015,23(5):354-357.
    [11] TRIPATHI D,STANLEY AJ,HAYES PC,et al. U. K. guidelines on the management of variceal haemorrhage in cirrhotic patients[J]. Gut,2015,64(11):1680-1704.
    [12] Chinese Society of Hepatology,Chinese Medical Association.Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol,2017,10(33):1847-1863.(in Chinese)中华医学会肝病学分会．肝硬化腹水及相关并发症的诊疗指南[J]．临床肝胆病杂志，2017,10(33):1847-1863.
    [13] BERCU ZL,FISCHMAN AM,KIM E,et al. TIPS for refractory ascites:A 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts[J]. AJR Am J Roentgenol,2015,204(3):654-661.
    [14] CHU JG,SUN XL,PIAO LS,et al. Portosystemic shunt via left branch of portal vein for the prevention of encephalopathy following transjugular intrahepatic portosystemic shunt[J]. Chin J Hepatol,2002,10(6):437-440.(in Chinese)褚建国，孙晓丽，朴龙松，等．门静脉左支分流降低术后肝性脑病的临床研究[J]．中华肝脏病杂志，2002,10(6):437-440.
    [15] MOGICATO G,VAUTAVERS G,MEYNAUD-COLLARD P,et al. Blood flows in tributaries of the portal vein:Anatomical andangiographic studies in normal beagle dogs[J]. Anat Histol Embryol,2015,44(6):460-467.
    [16] LJUBICIC N,DUVNJAK M,ROTKVIC I,et al. Influence of the degree of liver failure on portal blood flow in patientswith liver cirrhosis[J]. Scand J Gastroenterol,1990,25(4):395-400.
    [17] QIN JP,JIANG MD,TANG W,et al. Clinical effects and complications of TIPS for portal hypertension due to cirrhosis:A single center[J]. World J Gastroenter,2013,19(44):8085-8092.
    [18] CHARON JP,ALAEDDIN FH,PIMPALWAR SA,et al. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation[J]. J Vasc Interv Radiol,2004,15(11):1219-1230.
    [19] VIGNALI C,BARGELLINI I,GROSSO M,et al. TIPS with expanded polytetrafluoroethylene-covered stent:Results of an Italian multicenter study[J]. AJR Am J Roentgenol,2005,185(2):472-480.
    [20] ANGELONI S,MERLI M,SALVATORI FM,et al. Polytetrafluoroethylene-covered stent grafts for TIPS procedure:1-year patency and clinical results[J]. Am J Gastroenterol,2004,99(2):280-285.
    [21] DARCY M. Evaluation and management of transjugularintra hepatic portosystemic shunts[J]. Am J Roentgenol,2012,199(4):730-736.
    [22] SAAD WE,DARWISH WM,DAVIES MG,et al. Stent-grafts for transjugular intrahepatic portosystemic shunt creation:Specialized TIPS stent-graft versus generic stent-graft/bare stent combination[J]. J Vasc Interv Radiol,2010,21(10):1512-1520.
    • Relative Articles

  • Relative Articles

    [1]Huang Shan, Zhou Hao, Chen XueLing, Yao Xin, Tang ShanHong, Yang GuoDong, Qin JianPing. Effect of transjugular intrahepatic portosystemic shunt on the liver and the heart[J]. Journal of Clinical Hepatology, 2020, 36(4): 904-907. doi: 10.3969/j.issn.1001-5256.2020.04.043
    [2]Wang Zhong, Liu FuQuan. Research advances in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2019, 35(12): 2824-2827. doi: 10.3969/j.issn.1001-5256.2019.12.040
    [3]Zou SongLong, Xu Ying. Prognostic evaluation of transjugular intrahepatic portosystemic shunt in treatment of cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2019, 35(1): 201-204. doi: 10.3969/j.issn.1001-5256.2019.01.044
    [4]Xi XiaoTan, Luo XueFeng, Zhu YongJun, Wang XiaoZe, Yang Li. A case of arterio-biliary fistula during transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2019, 35(2): 376-378. doi: 10.3969/j.issn.1001-5256.2019.02.027
    [5]The Chinese College of Interventionalists. CCI clinical practice guidelines: Management of TIPS for portal hypertension (2019 edition)[J]. Journal of Clinical Hepatology, 2019, 35(12): 2694-2699. doi: 10.3969/j.issn.1001-5256.2019.12.010
    [6]Yao Xin, Zhou Hao, Tang ShanHong, Xie Min, Huang Shan, Qin JianPing. Stent dysfunction after transjugular intrahepatic portosystemic shunt: Causes and countermeasures[J]. Journal of Clinical Hepatology, 2019, 35(5): 1052-1056. doi: 10.3969/j.issn.1001-5256.2019.05.023
    [7]Guo DanDan, Tang ShaoShan. Value of advanced dynamic flow versus color Doppler flow imaging in evaluating stent patency after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2018, 34(12): 2599-2602. doi: 10.3969/j.issn.1001-5256.2018.12.018
    [8]Ding ZhiFeng, Yin ShiWu, Zhang GuoBing, Wang MingQuan, Pan ShengQuan. Clinical effect of Viatorr stent versus double-stent technique in transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2018, 34(3): 579-582. doi: 10.3969/j.issn.1001-5256.2018.03.026
    [9]Ding ZhiFeng, Yin ShiWu. Application of Viatorr covered stent in transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2018, 34(5): 1107-1110. doi: 10.3969/j.issn.1001-5256.2018.05.039
    [10]Zhang XinTong, Qi XingShun, Luo JianJun, Guo XiaoZhong. An excerpt of consensus conference on TIPS management: techniques, indications, contraindications (Italy, 2016)[J]. Journal of Clinical Hepatology, 2017, 33(3): 428-431. doi: 10.3969/j.issn.1001-5256.2017.03.005
    [11]Interventional Group, Chinese Society of Radiology, Chinese Medical Association. Expert consensus on transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2017, 33(7): 1218-1228. doi: 10.3969/j.issn.1001-5256.2017.07.004
    [12]Niu Meng, Sun Jun, Xu Ke, Zhong HongShan. Retrospects and prospects of transjugular intrahepatic portosystemic shunt in China[J]. Journal of Clinical Hepatology, 2016, 32(2): 230-233. doi: 10.3969/j.issn.1001-5256.2016.02.005
    [13]Zhai YaNan, Li Lei, Yin Liang, Guo QiHong, Lei JunQiang, Guo ShunLin, Zhang ChunYu, Wang HaiJun, Wen XiaoXiao. Role of dual-source CT low-dose whole liver perfusion imaging in evaluating liver blood perfusion after transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal hypertension[J]. Journal of Clinical Hepatology, 2016, 32(10): 1894-1899. doi: 10.3969/j.issn.1001-5256.2016.10.014
    [14]Zhang Wei, ZhuGe YuZheng, Zhang Ming, He QiBin, Zhang Feng, Wang Yi, Zou XiaoPing. Therapeutic effect and safety of transjugular intrahepatic portosystemic shunt in patients with primary biliary cirrhosis and portal hypertension[J]. Journal of Clinical Hepatology, 2016, 32(2): 259-263. doi: 10.3969/j.issn.1001-5256.2016.02.012
    [15]Xu ZhengGuo, Zhao YongBing, Zheng YuanYu, Liu En, Yang ShiMing. Association between portal vein pressure drop gradient after transjugular intrahepatic portosystemic shunt and clinical prognosis[J]. Journal of Clinical Hepatology, 2016, 32(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2016.12.019
    [16]Ren ShuYao, Chen Hui, Lu: Yong, Wang ZhengYu, Niu Jing, Yin ZhanXin, He ChuangYe, Guo WenGang, Han GuoHong. Hepatic myelopathy after transjugular intrahepatic portosystemic shunt:natural course,survival analysis,and treatment[J]. Journal of Clinical Hepatology, 2016, 32(6): 1112-1117. doi: 10.3969/j.issn.1001-5256.2016.06.018
    [17]Xu Lu, Xiao Xue, Liu JingQi, Wang Jing, Zhou JingJing, Jiang ChunMeng. Influence of covered stent versus bare stent on long-term efficacy of transjugular intrahepatic portosystemic shunt: a Meta-analysis[J]. Journal of Clinical Hepatology, 2016, 32(10): 1900-1905. doi: 10.3969/j.issn.1001-5256.2016.10.015
    [18]Wang TingTing, Zhang Feng, ZhuGe YuZheng. Research progress in TIPS shunt dysfunction and recanalization[J]. Journal of Clinical Hepatology, 2015, 31(11): 1921-1923. doi: 10.3969/j.issn.1001-5256.2015.11.041
    [19]Zheng LuanLuan, Han GuoHong, Fan DaiMing. Role of transjugular intrahepatic portosystemic shunt in prevention and treatment of variceal bleeding in liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(7): 687-690. doi: 10.3969/j.issn.1001-5256.2014.07.031
    [20]Tang ShanHong, Qin JianPing, Jiang MingDe, Ceng WeiZheng, Yao Xin, He QianWen, Tang Wen, Gu Ming. Clinical effect and safety of TIPS in treatment of portal hypertension due to alcoholic cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(2): 145-148. doi: 10.3969/j.issn.1001-5256.2014.02.012
    • Supplements(0)
    • Cited By

  • Cited by

    Periodical cited type(11)

    1. 王旭，马志刚，刘丽丽，冯鹏丽，杨帆，杨永宾. TIPS术治疗失代偿期肝硬化患者术后短期肝脏体积增大的影响因素. 现代消化及介入诊疗. 2024(08): 971-974 .
    2. 中华医学会消化病学分会消化微创介入协作组. 经颈静脉肝内门体静脉分流术治疗门静脉高压专家共识. 中华消化杂志. 2023(05): 289-307 .
    3. 其七，姚欣，杨国栋，秦建平. 经颈静脉肝内门体分流术术中因素对术后发生肝性脑病的影响. 临床肝胆病杂志. 2023(08): 1966-1971 . 本站查看
    4. 唐承薇，张春清，诸葛宇征，吴浩，帖君，王广川，张明. 经颈静脉肝内门体静脉分流术治疗门静脉高压专家共识. 胃肠病学. 2023(06): 344-363 .
    5. 陈雪玲，姚欣，杨国栋，秦建平. 血管介入在肝硬化脾功能亢进中的应用研究进展. 世界华人消化杂志. 2022(03): 140-146 .
    6. Xin Yao，Sheng He，Meng Wei，Jian-Ping Qin. Influence of different portal vein branches on hepatic encephalopathy during intrahepatic portal shunt via jugular vein. World Journal of Gastroenterology. 2022(31): 4467-4470 .
    7. 刘琴，姚欣，李英，何胜，汤善宏，秦建平. 老年肝硬化患者经颈静脉肝内门体分流术后菌血症1例报告. 临床肝胆病杂志. 2022(10): 2337-2340 . 本站查看
    8. 中华医学会消化病学分会微创介入协作组. 经颈静脉肝内门体静脉分流术治疗门静脉高压专家共识(2022年版). 中华肝脏病杂志. 2022(12): 1349-1364 .
    9. 中华医学会消化病学分会微创介入协作组. 经颈静脉肝内门体静脉分流术治疗门静脉高压专家共识(2022年版). 中华肝脏病杂志. 2022(12): 1349-1364 .
    10. 刘海君. 护肝利水汤联合特利加压素治疗肝硬化腹水疗效及对患者血清指标与门静脉压力的影响. 按摩与康复医学. 2021(08): 74-76+79 .
    11. 黄山，姚欣，陈雪玲，周昊，陈虹彬，杨国栋，秦建平. 早期经颈静脉肝内门体分流术治疗老年肝硬化食管静脉曲张破裂出血的临床研究. 现代消化及介入诊疗. 2021(02): 197-201+207 .

    Other cited types(6)

  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-04010203040
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 2.4 %FULLTEXT: 2.4 %META: 91.7 %META: 91.7 %PDF: 6.0 %PDF: 6.0 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 7.0 %其他: 7.0 %其他: 1.0 %其他: 1.0 %China: 0.1 %China: 0.1 %India: 0.1 %India: 0.1 %Rochester: 0.1 %Rochester: 0.1 %Russian Federation: 0.1 %Russian Federation: 0.1 %上海: 2.7 %上海: 2.7 %北京: 4.2 %北京: 4.2 %南京: 0.1 %南京: 0.1 %南宁: 0.1 %南宁: 0.1 %南昌: 0.1 %南昌: 0.1 %吉林: 0.6 %吉林: 0.6 %哥伦布: 0.3 %哥伦布: 0.3 %墨尔本: 0.1 %墨尔本: 0.1 %大急流城: 0.1 %大急流城: 0.1 %大连: 0.1 %大连: 0.1 %天津: 0.1 %天津: 0.1 %奥马哈: 0.1 %奥马哈: 0.1 %宁波: 0.1 %宁波: 0.1 %安庆: 0.1 %安庆: 0.1 %宜宾: 0.1 %宜宾: 0.1 %广州: 0.3 %广州: 0.3 %张家口: 3.3 %张家口: 3.3 %徐州: 0.3 %徐州: 0.3 %德阳: 0.9 %德阳: 0.9 %成都: 1.9 %成都: 1.9 %昆明: 0.3 %昆明: 0.3 %杭州: 0.3 %杭州: 0.3 %武威: 0.1 %武威: 0.1 %武汉: 1.2 %武汉: 1.2 %沈阳: 0.1 %沈阳: 0.1 %济南: 0.6 %济南: 0.6 %漯河: 0.1 %漯河: 0.1 %玉林: 0.1 %玉林: 0.1 %石家庄: 0.3 %石家庄: 0.3 %纽约: 0.1 %纽约: 0.1 %绍兴: 0.1 %绍兴: 0.1 %罗奥尔凯埃: 0.6 %罗奥尔凯埃: 0.6 %芒廷维尤: 34.5 %芒廷维尤: 34.5 %芝加哥: 0.3 %芝加哥: 0.3 %莫斯科: 2.4 %莫斯科: 2.4 %襄阳: 0.1 %襄阳: 0.1 %西宁: 30.4 %西宁: 30.4 %诺沃克: 0.1 %诺沃克: 0.1 %运城: 0.3 %运城: 0.3 %邯郸: 0.1 %邯郸: 0.1 %重庆: 0.4 %重庆: 0.4 %银川: 0.3 %银川: 0.3 %长春: 1.3 %长春: 1.3 %长沙: 0.3 %长沙: 0.3 %长治: 0.1 %长治: 0.1 %阜新: 0.1 %阜新: 0.1 %青岛: 0.1 %青岛: 0.1 %其他其他ChinaIndiaRochesterRussian Federation上海北京南京南宁南昌吉林哥伦布墨尔本大急流城大连天津奥马哈宁波安庆宜宾广州张家口徐州德阳成都昆明杭州武威武汉沈阳济南漯河玉林石家庄纽约绍兴罗奥尔凯埃芒廷维尤芝加哥莫斯科襄阳西宁诺沃克运城邯郸重庆银川长春长沙长治阜新青岛

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1447) PDF downloads(130) Cited by(17)
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[1835]YesterdayPV[3810]TodayIP[2318]TodayPV[4836]Online[81]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return